ERBB2 and triple-negative breast carcinoma: These include: (1) the estrogen receptor (ERα)/progesterone receptor (PR); (2) human epidermal growth factor receptor 2 (HER2); and (3) triple-negative breast cancers (TNBC) that do not express any of these three receptors [21,22,23].